Innophos

Cranbury, United States Founded: 2004 • Age: 22 yrs Listed Acquired By One Rock Capital Partners
Manufacturer of specialty phosphates, chelated minerals, and nutritional ingredients

About Innophos

Innophos is a company based in Cranbury (United States) founded in 2004, and was acquired by One Rock Capital Partners in October 2019. It operates as a manufacturer of specialty phosphates, chelated minerals, and nutritional ingredients. Innophos has completed 4 acquisitions, including Kelatron, Novel Ingredient and NutraGenesis. Its website innophos.com draws about 21 thousand monthly visits. Innophos offers products and services including Specialty Phosphates and Chelated Minerals.

Company details

Innophos was founded in 2004 and is headquartered in Cranbury, United States. Operations focus on the production of specialty phosphates, chelated minerals, and nutritional ingredients for applications in food and beverage, health and nutrition, and industrial sectors. Phosphate blends and mineral products are developed to meet customer requirements. Manufacturing processes are maintained for quality and supply chain reliability, with research and development supporting product innovation.

Key Metrics

Products & Services of Innophos

Innophos offers a comprehensive portfolio of products and services, including Specialty Phosphates and Chelated Minerals.

Specialty Phosphates
Chemical Products

Specialty phosphates are produced for use in food, health, and industrial applications, including baking and nutrition enhancements.

Chelated Minerals
Nutritional Products

Chelated minerals are developed to support health and nutrition, such as chelamax minerals that are utilized in dietary supplements and pharmaceuticals.

Apps and channels of Innophos

its YouTube channel Innophos Inc has 160 subscribers and 25 videos.

Innophos Inc
YouTube 160 subscribers 25 videos Science & Technology
Open channel

Videos from Innophos

The most watched videos on Innophos's YouTube channel, Innophos Inc (160 subscribers). Click a video to play it here.

The Science Behind Chelated Minerals (Full Presentation) | Innophos
2.4K views
VersaCal: Replacing Titanium Dioxide (TiO2) in Clean Label Products (Highlight) | Innophos
1.5K views
Zinc Bisglycinate for Immune Health: A Superior Alternative to Traditional Zinc Webinar | Innophos
1.1K views
Understanding Chelated Minerals | Innophos
910 views

More on Innophos Inc.

Investors in Innophos

Innophos has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include One Rock Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
A private equity firm focused on value creation is operated.
–onerock.comNew York, United States
Premium access

Investor details for Innophos

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Innophos

108 people are tracked at Innophos (30 in leadership, 7 in board & advisors, 71 in team).

NameRoleGroup
Joshua Horenstein
SVP, Chief Legal and Human Resources Officer & Corporate SecretaryLeadership
Carmela Manzo
Director Total RewardsLeadership
Sherry Duff
SVP, Chief Marketing and Technology OfficerLeadership
Mark Feuerbach
SVP & Interim Chief Financial OfficerLeadership
Suresh Gautham Sivanesan
IT Director - Business Process TransformationsLeadership
Valerie Coyne
Director, Digital MarketingLeadership
William Dunworth
VP Corporate Controller and Chief Accounting OfficerLeadership
Francisco Carrera
Director De Recursos HumanosLeadership
Viktoryia Makartychan Phr, Shrm-Cp
Director, Compensation And HR AnalyticsLeadership
Wilma Harris
VP Human ResourcesLeadership
James McGuire
Human Resources DirectorLeadership
Rich C.
Senior Director, Human ResourcesLeadership
Clarice Fukuya
Latin America Sales DirectorLeadership
Migue Dejong
Commercial Director, Food, Health And InternationalLeadership
David Madison
Commercial Sales Director - Nutraceutical IngredientsLeadership
Marco Coen
Senior Vice President, Chief Commercial OfficerLeadership
Leon Buzali
Commercial Director - Industrial SpecialtiesLeadership
David Lim
Vice President - FinanceLeadership
Sandra Pereira
Senior Director FinanceLeadership
Dennis Loughran
Senior Vice President, Chief Financial OfficerLeadership

88 more people are available in the full profile.

Premium access

Complete people profiles for Innophos

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Innophos

Innophos has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Kelatron, Novel Ingredient and NutraGenesis.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Clinically tested nutraceutical ingredients are developed and supplied globally.
nutragenesis.comBrattleboro, United States2002Nov 2017$28M
Nutraceutical ingredients are manufactured and marketed by Novel Ingredient.
novelingredient.comEast Hanover, United States1995Aug 2017$125M
Natural food ingredients are manufactured for various applications.
triarco.comCranbury, United States1978Jan 2013$46M
Chelated minerals and premixes are manufactured for nutritional industries.
kelatron.comOgden, United States1985Oct 2011$21M
Premium access

Complete acquisition details for Innophos

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Innophos

7 dated milestones of Innophos across 15 years, from founding to its latest funding, stage changes and deals.

  1. Founded Innophos is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Kelatron.
  4. Acquisition Acquires Triarco Industries.
  5. Acquisition Acquires Novel Ingredient.
  6. Acquisition Acquires NutraGenesis.
  7. Exit Acquired by One Rock Capital Partners.

Web traffic of Innophos

The website of Innophos (innophos.com) receives about 21.3K visits a month.

  • Monthly visits
    21.3K

    ▲ 24.5% vs previous month

Similar websites

Websites whose visitors overlap most with Innophos. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cometchemical.com
cometchemical.com
100%
–#5,897,584–
kurita.eu
98%
–#3,072,737View details
doc.ccc-group.com
doc.ccc-group.com
97%
–––
harke.com
95%
–#1,841,756View details
powderbulksolids.com
94%
26.9K#1,199,353View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Innophos

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Innophos

Premium access

Complete news archive for Innophos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Innophos

Innophos was founded in 2004.

Innophos is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.

Innophos was founded in 2004 and is headquartered in Cranbury, United States. Operations focus on the production of specialty phosphates, chelated minerals, and nutritional ingredients for applications in food and beverage, health and nutrition, and industrial sectors. Phosphate blends and mineral products are developed to meet customer requirements. Manufacturing processes are maintained for quality and supply chain reliability, with research and development supporting product innovation.

Innophos offers Specialty Phosphates and Chelated Minerals.

Innophos has made 4 acquisitions, including Kelatron, Novel Ingredient, and NutraGenesis.

Innophos has 1 investor. Key investors include One Rock Capital Partners.

Innophos operates through Innophos.

Yes. Innophos was acquired by One Rock Capital Partners in October 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available